The role of nitric oxide in the pathogenesis of brain lesions during the development of Alzheimer's disease

In Vivo

Volumn 18, Issue 3, 2004, Pages 325-334

  Seyidova, Dilara ^a   Aliyev, Ali ^a   Rzayev, Nizami ^a   Obrenovich, Mark ^a   Lamb, Bruce T ^a   Smith, Mark A ^a   De La Torre, Jack C ^a   Perry, George ^a   Aliev, Gjumrakch ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Alzheimer's disease; Hypoperfusion; Nitric oxide; Review; Vessel lesion

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; ANGIOTENSIN; ARGININE; CALCIMYCIN; DIMETHYLARGININASE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; INDUCIBLE NITRIC OXIDE SYNTHASE; NEURONAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE; PEROXYNITRITE; VALSARTAN;

ALZHEIMER DISEASE; BLOOD VESSEL TONE; BRAIN BLOOD FLOW; BRAIN BLOOD VESSEL; BRAIN INJURY; CELL COMPARTMENTALIZATION; CELL MEMBRANE PERMEABILITY; DRUG MECHANISM; ENZYME ACTIVITY; GENE OVEREXPRESSION; IMMUNOCYTOCHEMISTRY; IMMUNOPRECIPITATION; INTRACELLULAR SPACE; NONHUMAN; PATHOGENESIS; REVIEW; VASODILATATION;

EID: 4043109229     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (76)

1. Aliev G: Is non-genetic Alzheimer's disease a vascular disorder with neurodegenerative consequences? J Alzheimer's Disease 4(6): 513-6, 2002.
2. Aliev G and Burnstock G: Watanabe rabbits with heritable hypercholesterolaemia: a model of atherosclerosis. Histol Histopathol 13(3): 797-817, 1998.
3. Aliev G, Cirillo R, Salvatico E, Paro M and Prosdocimi M: Changes in vessel ultrastructure during ischemia and reperfusion of rabbit hindlimb: implications for therapeutic intervention. Microvasc Res 46(1): 65-76, 1993.
4. Aliev G, Ralevic V and Burnstock G: Depression of endothelial nitric oxide synthase but increased expression of endothelin-1 immunoreactivity in rat thoracic aortic endothelium associated with long-term, but not short-term, sympathectomy. Circ Res 79(2): 317-23, 1996.
5. Aliev G, Seyidova D, Lamb BT, Neal ML, Siedlak SL, Vinters H, LaManna JC, Friedland RP, Head E, Perry G and Cotman CW: Atherosclerotic lesions and mitochondria DNA deletions in brain microvessels as a central target for the development of human AD and AD-like pathology in aged YAC AβPP transgenic mice. Ann NY Acad Sci 977: 45-64, 2002.
6. Aliev G, Seyidova D, Raina AK, Obrenovich ME, Neal ML, Siedlak SL, Lamb BT, Vinters H, LaManna JC, Smith MA and Perry G: Vascular hypoperfusion, mitochondria failure and oxidative stress in Alzheimer Disease. Proc Indian Nat Sci Academ B69(2): 209-38, 2003.
7. Aliev G, Shi J, Perry G, Friedland RP and Lamanna JC: Decreased constitutive nitric oxide synthase, but increased inducible nitric oxide synthase and endothelin-1 immunoreactivity in aortic endothelial cells of Donryu rats on a cholesterol-enriched diet. Anat Rec 260(1): 16-25, 2000.
8. Aliev G, Smith MA, Seyidova D, Neal ML, Shi J, Loizidou M, Turmaine M, Friedland RP, Taylor I, Burnstock G, Perry G and Lamanna JC: Increased expression of NOS and ET-1 immunoreactivity in human colorectal metastatic liver tumours is associated with selective depression of constitutive NOS immunoreactivity in vessel endothelium. J Submicrosc Cytol Pathol 34(1): 37-50, 2002.
9. Aliev G, Smith MA, Vinters H, Johnson AB, Nunomura A and Perry G: Mitochondria abnormalities mark vulnerable neurons in Alzheimer's Disease. J Neuropathol Exp Neurol 58: 511, 1999.
10. Almeida A, Bolanos JP and Medina JM: Nitric oxide mediates glutamate-induced mitochondrial depolarization in rat cortical neurons. Brain Res 816(2): 580-6, 1999.
11. Bates TE, Loesch A, Burnstock G and Clark JB: Mitochondrial nitric oxide synthase: a ubiquitous regulator of oxidative phosphorylation? Biochem Biophys Res Commun 218(1): 40-4, 1996.
12. Bayraktutan U and Ulker S: Effects of angiotensin II on nitric oxide generation in proliferating and quiescent rat coronary microvascular endothelial cells. Hypertens Res 26(9): 749-57, 2003.
13. Beal MF: Aging, energy and oxidative stress in neurodegenerative diseases. Ann Neurol 38(3): 357-66, 1995.
14. Beckman JS: The double-edged role of nitric oxide in brain function and superoxide-mediated injury. J Dev Physiol 15(1): 53-9, 1991.
15. Beckman JS, Beckman TW, Chen J, Marshall PA and Freeman BA: Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA 87(4): 1620-4,1990.
16. Beckman JS, Carson M, Smith CD and Koppenol WH: ALS, SOD and peroxynitrite. Nature 364(6438): 584, 1993.
17. Bogumil R, Knipp M, Fundel SM and Vasak M: Characterization of dimethylargininase from bovine brain: evidence for a zinc binding site. Biochemistry 37(14): 4791-8, 1998.
18. Bredt DS and Snyder SH: Nitric oxide: a physiologic messenger molecule. Annu Rev Biochem 63: 175-95, 1994.
19. Buisson A, Margaill I, Callebert J, Plotkine M and Boulu RG: Mechanisms involved in the neuroprotective activity of a nitric oxide synthase inhibitor during focal cerebral ischemia. J Neurochem 61(2): 690-6, 1993.
20. Buisson A, Plotkine M and Boulu RG: The neuroprotective effect of a nitric oxide inhibitor in a rat model of focal cerebral ischaemia. Br J Pharmacol 106(4): 766-7, 1992.
21. Cao S, Yao J, McCabe TJ, Yao Q, Katusic ZS, Sessa WC and Shah V: Direct interaction between endothelial nitric-oxide synthase and dynamin-2. Implications for nitric-oxide synthase function. J Biol Chem 276(17): 14249-56, 2001.
22. Cao S, Yao J and Shah V: The proline-rich domain of dynamin-2 is responsible for dynamin-dependent in vitro potentiation of endothelial nitric-oxide synthase activity via selective effects on reductase domain function. J Biol Chem 278(8): 5894-901, 2003.
23. Cazevieille C, Muller A, Meynier F and Bonne C: Superoxide and nitric oxide cooperation in hypoxia/reoxygenation-induced neuron injury. Free Radic Biol Med 14(4): 389-95, 1993.
24. Crow JP, Ye YZ, Strong M, Kirk M, Barnes S and Beckman JS: Superoxide dismutase catalyzes nitration of tyrosines by peroxynitrite in the rod and head domains of neurofilament-L. J Neurochem 69(5): 1945-53, 1997.
25. Dawson DA: Nitric oxide and focal cerebral ischemia: multiplicity of actions and diverse outcome. Cerebrovasc Brain Metab Rev 6(4): 299-324, 1994.
26. Dawson VL, Brahmbhatt HP, Mong JA and Dawson TM: Expression of inducible nitric oxide synthase causes delayed neurotoxicity in primary mixed neuronal-glial cortical cultures. Neuropharmacology 33(11): 1425-30, 1994.
27. Dawson VL and Dawson TM: Nitric oxide in neuronal degeneration. Proc Soc Exp Biol Med 211(1): 33-40, 1996.
28. Dawson VL, Dawson TM, London ED, Bredt DS and Snyder SH: Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures. Proc Natl Acad Sci USA 88(14): 6368-71, 1991.
29. de la Torre JC: Alzheimer's disease as a vascular disorder: nosological evidence. Stroke 33(4): 1152-62, 2002.
30. de la Torre JC: Alzheimer's disease: How does it start? J Alzheimer's Disease 4(6): 497-512, 2002.
31. de la Torre JC: Is Alzheimer's disease a neurodegenerative or a vascular disorder? Data, dogma and dialectics. Lancet Neurol 3(3): 184-90, 2004.
32. de la Torre JC and Stefano GB: Evidence that Alzheimer's disease is a microvascular disorder: the role of constitutive nitric oxide. Brain Res Brain Res Rev 34(3): 119-36, 2000.
33. Faraci FM: Role of endothelium-derived relaxing factor in cerebral circulation: large arteries vs. microcirculation. Am J Physiol 261(4 Pt 2): H1038-H1042, 1991.
34. Faraci FM and Brian JE: Nitric oxide and the cerebral circulation. Stroke 25(3): 692-703, 1994.
35. Garthwaite J and Beaumont PS: Excitatory amino acid receptors in the parallel fibre pathway in rat cerebellar slices. Neurosci Lett 107(1-3): 151-6, 1989.
36. Hamada Y, Hayakawa T, Hattori H and Mikawa H: Inhibitor of nitric oxide synthesis reduces hypoxic-ischemic brain damage in the neonatal rat. Pediatr Res 35(1): 10-4, 1994.
37. Hara H, Huang PL, Panahian N, Fishman MC and Moskowitz MA: Reduced brain edema and infarction volume in mice lacking the neuronal isoform of nitric oxide synthase after transient MCA occlusion. J Cereb Blood Flow Metab 16(4): 605-11, 1996.
38. Harrison DG and Cai H: Endothelial control of vasomotion and nitric oxide production. Cardiol Clin 21(3):289-302, 2003.
39. Huang Z, Huang PL, Panahian N, Dalkara T, Fishman MC and Moskowitz MA: Effects of cerebral ischemia in mice deficient in neuronal nitric oxide synthase. Science 265(5180): 1883-5, 1994.
40. Iadecola C: Does nitric oxide mediate the increases in cerebral blood flow elicited by hypercapnia? Proc Natl Acad Sci USA 89(9): 3913-6, 1992.
41. Iadecola C, Li J, Ebner TJ and Xu X: Nitric oxide contributes to functional hyperemia in cerebellar cortex. Am J Physiol 268(5 Pt 2): R1153-R1162, 1995.
42. Iadecola C, Zhang F, Casey R, Clark HB and Ross ME: Inducible nitric oxide synthase gene expression in vascular cells after transient focal cerebral ischemia. Stroke 27(8): 1373-80, 1996.
43. Iadecola C, Zhang F, Xu S, Casey R and Ross ME: Inducible nitric oxide synthase gene expression in brain following cerebral ischemia. J Cereb Blood Flow Metab 15(3): 378-84, 1995.
44. Iadecola C, Zhang F and Xu X: Inhibition of inducible nitric oxide synthase ameliorates cerebral ischemic damage. Am J Physiol 268(1 Pt 2): R286-R292, 1995.
45. Kara P and Friedlander MJ: Dynamic modulation of cerebral cortex synaptic function by nitric oxide. Prog Brain Res 118: 183-98, 1998.
46. Kimoto M, Tsuji H, Ogawa T and Sasaoka K: Detection of NG, NG-dimethylarginine dimethylaminohydrolase in the nitric oxide-generating systems of rats using monoclonal antibody. Arch Biochem Biophys 300(2): 657-62, 1993.
47. Kimoto M, Whitley GS, Tsuji H and Ogawa T: Detection of NG, NG-dimethylarginine dimethylaminohydrolase in human tissues using a monoclonal antibody. J Biochem (Tokyo) 117(2): 237-8, 1995.
48. Kimura C, Oike M, Ohnaka K, Nose Y and Ito Y: Constitutive nitric oxide production in bovine aortic and brain microvascular endothelial cells: a comparative study. J Physiol 554(Pt 3): 721-30, 2004.
49. Lafon-Cazal M, Culcasi M, Gaven F, Pietri S and Bockaert J: Nitric oxide, superoxide and peroxynitrite: putative mediators of NMDA-induced cell death in cerebellar granule cells. Neuropharmacology 32(11): 1259-66, 1993.
50. Lafon-Cazal M, Pietri S, Culcasi M and Bockaert J: NMDA-dependent superoxide production and neurotoxicity. Nature 364(6437): 535-7, 1993.
51. Liu J and Sessa WC: Identification of covalently bound amino-terminal myristic acid in endothelial nitric oxide synthase. J Biol Chem 269(16): 11691-4, 1994.
52. MacAllister RJ, Parry H, Kimoto M, Ogawa T, Russell RJ, Hodson H, Whitley GS and Vallance P: Regulation of nitric oxide synthesis by dimethylarginine dimethylaminohydrolase. Br J Pharmacol 119(8): 1533-40, 1996.
53. Marletta MA: Nitric oxide synthase: aspects concerning structure and catalysis. Cell 78(6): 927-30, 1994.
54. Michel T and Feron O: Nitric oxide synthases: which, where, how and why? J Clin Invest 100(9): 2146-52, 1997.
55. Moncada S and Higgs EA: Molecular mechanisms and therapeutic strategies related to nitric oxide. FASEB J 9(13): 1319-30, 1995.
56. Moncada S, Palmer RM and Higgs EA: Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev 43(2): 109-42, 1991.
57. Morris SM and Billiar TR: New insights into the regulation of inducible nitric oxide synthesis. Am J Physiol 266(6 Pt 1): E829-E839, 1994.
58. Nakashima MN, Yamashita K, Kataoka Y, Yamashita YS and Niwa M: Time course of nitric oxide synthase activity in neuronal, glial and endothelial cells of rat striatum following focal cerebral ischemia. Cell Mol Neurobiol 15(3): 341-9, 1995.
59. Park CS, Pardhasaradhi K, Gianotti C, Villegas E and Krishna G: Human retina expresses both constitutive and inducible isoforms of nitric oxide synthase MRNA. Biochem Biophys Res Commun 205(1): 85-91, 1994.
60. Radi R, Beckman JS, Bush KM and Freeman BA: Peroxynitrite oxidation of sulfhydryls. The cytotoxic potential of superoxide and nitric oxide. J Biol Chem 266(7): 4244-50, 1991.
61. Ravichandran LV, Johns RA and Rengasamy A: Direct and reversible inhibition of endothelial nitric oxide synthase by nitric oxide. Am J Physiol 268(6 Pt 2): H2216-H2223, 1995.
62. Rengasamy A and Johns RA: Inhibition of nitric oxide synthase by a superoxide generating system. J Pharmacol Exp Ther 267(3): 1024-7, 1993.
63. Robinson LJ, Weremowicz S, Morton CC and Michel T: Isolation and chromosomal localization of the human endothelial nitric oxide synthase (NOS3) gene. Genomics 19(2): 350-7, 1994.
64. Samadani AF, Dawson TM and Dawson VL: Nitric oxide synthase in model of focal ischemia. Stroke 28: 1283-8, 1997.
65. Sessa WC: The nitric oxide synthase family of proteins. J Vasc Res 31(3): 131-43, 1994.
66. Shin T, Weinstock D, Castro MD, Acland H, Walter M, Kim HY and Purchase HG: Immunohistochemical study of constitutive neuronal and inducible nitric oxide synthase in the central nervous system of goat with natural listeriosis. J Vet Sci 1(2): 77-80, 2000.
67. Smith MA, Richey Harris PL, Sayre LM, Beckman JS and Perry G: Widespread peroxynitrite-mediated damage in Alzheimer's disease. J Neurosci 17(8): 2653-7, 1997.
68. Smith MA, Sayre LM and Perry G: Is Alzheimer's disease of oxidative stress? Alzheimer's Disease Rev 1: 63-7, 1996.
69. Smith MA, Vasak M, Knipp M, Castellani RJ and Perry G: Dimethylargininase, a nitric oxide regulatory protein, in Alzheimer disease. Free Radic Biol Med 25(8): 898-902, 1998.
70. Stamler JS: Redox signaling: Nitrosylation and related target interactions of nitric oxide. Cell 78(6): 931-6, 1994.
71. Stuehr DJ: Structure-function aspects in the nitric oxide synthases. Annu Rev Pharmacol Toxicol 37(6): 339-59, 1997.
72. Thorns V, Hansen L and Masliah E: NNOS expressing neurons in the entorhinal cortex and hippocampus are affected in patients with Alzheimer's disease. Exp Neurol 150(1): 14-20, 1998.
73. Wang Q, Pelligrino DA, Baughman VL, Koenig HM and Albrecht RF: The role of neuronal nitric oxide synthase in regulation of cerebral blood flow in normocapnia and hypercapnia in rats. J Cereb Blood Flow Metab 15(5): 774-8, 1995.
74. Wever RMF, Luscher TF, Cosentino F and Rabelink TJ: Atherosclerosis and the two faces of endothelial nitric oxide synthase. Circulation 97: 108-12, 1998.
75. Xia Y, Dawson VL, Dawson TM, Snyder SH and Zweier JL: Nitric oxide synthase generates superoxide and nitric oxide in arginine-depleted cells leading to peroxynitrite-mediated cellular injury. Proc Natl Acad Sci USA 93(13): 6770-4, 1996.
76. 2+ channels. J Hypertens Suppl 6(4): S188-S191, 1988.